ENG_RE Home  

PubMed@dpavot:33053024_en_relations JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T0 28-34 HP_0012828 denotes severe
T1 28-61 DOID_2945 denotes severe acute respiratory syndrome
T2 35-40 HP_0011009 denotes acute
T3 53-61 DOID_225 denotes syndrome
T4 170-190 DOID_0080600 denotes SARS-CoV-2 infection
T5 204-211 DOID_4 denotes disease
T6 219-227 DOID_0080600 denotes COVID-19
T7 232-247 DOID_10533 denotes viral pneumonia
T8 238-247 HP_0002090 denotes pneumonia
T9 238-247 DOID_552 denotes pneumonia
T10 348-353 HP_0011009 denotes acute
T11 348-383 DOID_11394 denotes acute respiratory distress syndrome
T12 354-374 HP_0002098 denotes respiratory distress
T13 375-383 DOID_225 denotes syndrome
T14 423-427 CHEBI_50906 denotes role
T15 431-446 CHEBI_50858 denotes corticosteroids
T16 463-468 HP_0011009 denotes acute
T17 463-498 DOID_11394 denotes acute respiratory distress syndrome
T18 469-489 HP_0002098 denotes respiratory distress
T19 490-498 DOID_225 denotes syndrome
T20 596-609 CHEBI_41879 denotes dexamethasone
T21 746-754 HP_0012826 denotes moderate
T22 758-764 HP_0012828 denotes severe
T23 765-770 HP_0011009 denotes acute
T24 765-800 DOID_11394 denotes acute respiratory distress syndrome
T25 771-791 HP_0002098 denotes respiratory distress
T26 792-800 DOID_225 denotes syndrome
T27 830-838 DOID_0080600 denotes COVID-19
T28 1021-1029 HP_0012826 denotes moderate
T29 1033-1039 HP_0012828 denotes severe
T30 1040-1045 HP_0011009 denotes acute
T31 1040-1075 DOID_11394 denotes acute respiratory distress syndrome
T32 1046-1066 HP_0002098 denotes respiratory distress
T33 1067-1075 DOID_225 denotes syndrome
T34 1116-1124 DOID_0080600 denotes COVID-19
T35 1205-1218 CHEBI_41879 denotes dexamethasone
T36 1270-1283 CHEBI_41879 denotes dexamethasone
T37 1349-1362 CHEBI_41879 denotes dexamethasone
T38 1415-1428 CHEBI_41879 denotes dexamethasone
R0 T1 T14 effect severe acute respiratory syndrome,role
R1 T1 T15 effect severe acute respiratory syndrome,corticosteroids
R10 T5 T20 effect disease,dexamethasone
R11 T5 T35 effect disease,dexamethasone
R12 T6 T14 effect COVID-19,role
R13 T6 T15 effect COVID-19,corticosteroids
R14 T6 T20 effect COVID-19,dexamethasone
R15 T6 T35 effect COVID-19,dexamethasone
R16 T7 T14 effect viral pneumonia,role
R17 T7 T15 effect viral pneumonia,corticosteroids
R18 T7 T20 effect viral pneumonia,dexamethasone
R19 T7 T35 effect viral pneumonia,dexamethasone
R2 T1 T20 effect severe acute respiratory syndrome,dexamethasone
R20 T13 T14 effect syndrome,role
R21 T13 T15 effect syndrome,corticosteroids
R22 T13 T20 effect syndrome,dexamethasone
R23 T13 T35 effect syndrome,dexamethasone
R24 T17 T14 effect acute respiratory distress syndrome,role
R25 T17 T15 effect acute respiratory distress syndrome,corticosteroids
R26 T17 T20 effect acute respiratory distress syndrome,dexamethasone
R27 T17 T35 effect acute respiratory distress syndrome,dexamethasone
R28 T24 T14 effect acute respiratory distress syndrome,role
R29 T24 T15 effect acute respiratory distress syndrome,corticosteroids
R3 T1 T35 effect severe acute respiratory syndrome,dexamethasone
R30 T24 T20 effect acute respiratory distress syndrome,dexamethasone
R31 T24 T35 effect acute respiratory distress syndrome,dexamethasone
R32 T27 T14 effect COVID-19,role
R33 T27 T15 effect COVID-19,corticosteroids
R34 T27 T20 effect COVID-19,dexamethasone
R35 T27 T35 effect COVID-19,dexamethasone
R36 T33 T14 effect syndrome,role
R37 T33 T15 effect syndrome,corticosteroids
R38 T33 T20 effect syndrome,dexamethasone
R39 T33 T35 effect syndrome,dexamethasone
R4 T4 T14 effect SARS-CoV-2 infection,role
R40 T34 T14 effect COVID-19,role
R41 T34 T15 effect COVID-19,corticosteroids
R42 T34 T20 effect COVID-19,dexamethasone
R43 T34 T35 effect COVID-19,dexamethasone
R5 T4 T15 effect SARS-CoV-2 infection,corticosteroids
R6 T4 T20 effect SARS-CoV-2 infection,dexamethasone
R7 T4 T35 effect SARS-CoV-2 infection,dexamethasone
R8 T5 T14 effect disease,role
R9 T5 T15 effect disease,corticosteroids